{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:25:48Z","timestamp":1793762748916,"version":"4.6.1"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T00:00:00Z","timestamp":1719532800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073709"],"award-info":[{"award-number":["82073709"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1-030"],"award-info":[{"award-number":["2021-I2M-1-030"]}],"id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.bioorg.2024.107584","type":"journal-article","created":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T04:57:39Z","timestamp":1719032259000},"page":"107584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Discovery of cinnamamide\/ester triazole hybrids as potential treatment for Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"150","author":[{"given":"Lin-Jie","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ju","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi-Min","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Di","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Lun","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo-Rong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9533","key":"10.1016\/j.bioorg.2024.107584_b0005","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(06)69113-7","article-title":"Alzheimer's disease","volume":"368","author":"Blennow","year":"2006","journal-title":"Lancet (london, England)"},{"issue":"1","key":"10.1016\/j.bioorg.2024.107584_b0010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/ene.13439","volume":"25","author":"Lane","year":"2018","journal-title":"Alzheimer's Disease. European Journal of Neurology"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107584_b0015","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.jalz.2007.04.381","article-title":"Forecasting the global burden of Alzheimer's disease","volume":"3","author":"Brookmeyer","year":"2007","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.bioorg.2024.107584_b0020","unstructured":"P Prince, M.J., Comas-Herrera, A., Knapp, M., Guerchet, M., & Karagiannidou, M. (2016). World Alzheimer report 2016: improving healthcare for people living with dementia: coverage, quality and costs now and in the future. https:\/\/search.informit.org\/doi\/10.3316\/apo.260046."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107584_b0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jalz.2012.11.007","article-title":"The global prevalence of dementia: a systematic review and metaanalysis","volume":"9","author":"Prince","year":"2013","journal-title":"Alzheimer's & Dementia : the Journal of the Alzheimer' Association"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107584_b0030","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jamaneurol.2013.5847","article-title":"Amyloid-\u03b2 and tau: the trigger and bullet in Alzheimer disease pathogenesis","volume":"71","author":"Bloom","year":"2014","journal-title":"JAMA Neurol."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107584_b0035","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2174\/1570159X13666150716165726","article-title":"Alzheimer's disease: Targeting the Cholinergic System","volume":"14","author":"Ferreira-Vieira","year":"2016","journal-title":"Curr. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107584_b0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/nrneurol.2015.225","article-title":"Tau and neurodegenerative disease: the story so far","volume":"12","author":"Iqbal","year":"2016","journal-title":"Nat. Rev. Neurol."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107584_b0045","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrn3880","article-title":"Immune attack: the role of inflammation in Alzheimer disease","volume":"16","author":"Heppner","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"issue":"7","key":"10.1016\/j.bioorg.2024.107584_b0050","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41582-018-0013-z","article-title":"Tau-targeting therapies for Alzheimer disease","volume":"14","author":"Congdon","year":"2018","journal-title":"Nat. Rev. Neurol."},{"issue":"19","key":"10.1016\/j.bioorg.2024.107584_b0055","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.2174\/0929867321666131227161303","article-title":"Oxidative stress mediated mitochondrial and vascular lesions as markers in the pathogenesis of Alzheimer disease","volume":"21","author":"Aliev","year":"2014","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107584_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101619","article-title":"Oxidative stress: The core pathogenesis and mechanism of Alzheimer's disease","volume":"77","author":"Bai","year":"2022","journal-title":"Ageing Res. Rev."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107584_b0065","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-132690","article-title":"Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis","volume":"41","author":"Tan","year":"2014","journal-title":"Journal of Alzheimer's Disease : JAD"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107584_b0070","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.3390\/pharmaceutics14061117","article-title":"Therapeutic Approach to Alzheimer's Disease: Current Treatments and New Perspectives","volume":"14","author":"Pardo-Moreno","year":"2022","journal-title":"Pharmaceutics"},{"issue":"10","key":"10.1016\/j.bioorg.2024.107584_b0075","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1080\/14740338.2018.1524870","article-title":"The efficacy and safety of memantine for the treatment of Alzheimer's disease","volume":"17","author":"Matsunaga","year":"2018","journal-title":"Expert Opin. Drug Saf."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107584_b0080","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s13311-023-01405-0","article-title":"Anti-Amyloid Immunotherapies for Alzheimer's Disease: A 2023 Clinical Update","volume":"20","author":"Yadollahikhales","year":"2023","journal-title":"Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics"},{"key":"10.1016\/j.bioorg.2024.107584_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.npep.2015.06.008","article-title":"Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease","volume":"52","author":"Barage","year":"2015","journal-title":"Neuropeptides"},{"issue":"7","key":"10.1016\/j.bioorg.2024.107584_b0090","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1093\/brain\/awy132","article-title":"The cholinergic system in the pathophysiology and treatment of Alzheimer's disease","volume":"141","author":"Hampel","year":"2018","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.bioorg.2024.107584_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115502","article-title":"Sulfur-fluoride exchange (SuFEx)-enabled lead discovery of AChE inhibitors by fragment linking strategies","volume":"257","author":"Zhang","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107584_b0100","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ejmech.2017.03.062","article-title":"Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease","volume":"132","author":"Li","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107584_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113735","article-title":"Novel cannabidiol-carbamate hybrids as selective BuChE inhibitors: Docking-based fragment reassembly for the development of potential therapeutic agents against Alzheimer's disease","volume":"223","author":"Jiang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107584_b0110","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1042\/BJ20130013","article-title":"Crystal structures of human cholinesterases in complex with huprine W and tacrine: elements of specificity for anti-Alzheimer's drugs targeting acetyl- and butyryl-cholinesterase","volume":"453","author":"Nachon","year":"2013","journal-title":"Biochem. J."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107584_b0115","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1517\/14728222.11.2.161","article-title":"Targeting acetylcholinesterase to treat neurodegeneration","volume":"11","author":"Holzgrabe","year":"2007","journal-title":"Expert Opin. Ther. Targets"},{"issue":"4","key":"10.1016\/j.bioorg.2024.107584_b0120","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0896-6273(00)80108-7","article-title":"Acetylcholinesterase accelerates assembly of amyloid-beta-peptides into Alzheimer's fibrils: possible role of the peripheral site of the enzyme","volume":"16","author":"Inestrosa","year":"1996","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107584_b0125","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0014-5793(99)00468-8","article-title":"Neurotoxicity of acetylcholinesterase amyloid beta-peptide aggregates is dependent on the type of Abeta peptide and the AChE concentration present in the complexes","volume":"450","author":"Mu\u00f1oz","year":"1999","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.bioorg.2024.107584_b0130","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/35067589","article-title":"Acetylcholinesterase\u2013new roles for an old actor","volume":"2","author":"Soreq","year":"2001","journal-title":"Nat. Rev. Neurosci."},{"issue":"13","key":"10.1016\/j.bioorg.2024.107584_b0135","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.2174\/0929867311320130007","article-title":"Multi-target compounds acting in the central nervous system designed from natural products","volume":"20","author":"Chen","year":"2013","journal-title":"Curr. Med. Chem."},{"issue":"18","key":"10.1016\/j.bioorg.2024.107584_b0140","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.3390\/nu14183709","article-title":"Recent Advances in the Neuroprotective Properties of Ferulic Acid in Alzheimer's Disease: A Narrative Review","volume":"14","author":"Di Giacomo","year":"2022","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.bioorg.2024.107584_b0145","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41401-023-01177-5","article-title":"Caffeic acid alleviates cerebral ischemic injury in rats by resisting ferroptosis via Nrf2 signaling pathway","volume":"45","author":"Li","year":"2024","journal-title":"Acta Pharmacol. Sin."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107584_b0150","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1039\/D0FO02784G","article-title":"Caffeic acid protects against A\u03b2 toxicity and prolongs lifespan in Caenorhabditis elegans models","volume":"12","author":"Li","year":"2021","journal-title":"Food Funct."},{"key":"10.1016\/j.bioorg.2024.107584_b0155","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neulet.2012.12.051","article-title":"Protective effects of caffeic acid and caffeic acid phenethyl ester against acrolein-induced neurotoxicity in HT22 mouse hippocampal cells","volume":"535","author":"Huang","year":"2013","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bioorg.2024.107584_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2021.104879","article-title":"Design, synthesis and evaluation of cinnamic acid hybrids as multi-target-directed agents for the treatment of Alzheimer's disease","volume":"112","author":"Wang","year":"2021","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2024.107584_b0165","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1080\/09168451.2015.1107463","article-title":"Water-soluble ferulic acid derivatives improve amyloid-\u03b2-induced neuronal cell death and dysmnesia through inhibition of amyloid-\u03b2 aggregation","volume":"80","author":"Kikugawa","year":"2016","journal-title":"Biosci. Biotech. Bioch."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107584_b0170","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1080\/14756366.2016.1256883","article-title":"Design, synthesis and evaluation of novel cinnamic acid derivatives bearing N-benzyl pyridinium moiety as multifunctional cholinesterase inhibitors for Alzheimer's disease","volume":"32","author":"Lan","year":"2017","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107584_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103844","article-title":"Design, synthesis and biological evaluation of novel carboline-cinnamic acid hybrids as multifunctional agents for treatment of Alzheimer's disease","volume":"99","author":"Liao","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2024.107584_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114695","article-title":"Recent advance on pleiotropic cholinesterase inhibitors bearing amyloid modulation efficacy","volume":"242","author":"Zhang","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107584_b0185","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejmech.2018.09.031","article-title":"Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease","volume":"158","author":"Li","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107584_b0190","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.pneurobio.2015.12.003","article-title":"Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease","volume":"151","author":"Ismaili","year":"2017","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.bioorg.2024.107584_b0195","doi-asserted-by":"crossref","unstructured":"da Silva, F.deC., de Souza, M. C., Frugulhetti, I. I., Castro, H. C., Souza, S. L., de Souza, T. M., Rodrigues, D. Q., Souza, A. M., Abreu, P. A., Passamani, F., Rodrigues, C. R., & Ferreira, V. F. (2009). Synthesis, HIV-RT inhibitory activity and SAR of 1-benzyl-1H-1,2,3-triazole derivatives of carbohydrates. European journal of medicinal chemistry, 44(1), 373\u2013383. 10.1016\/j.ejmech.2008.02.047.","DOI":"10.1016\/j.ejmech.2008.02.047"},{"key":"10.1016\/j.bioorg.2024.107584_b0200","doi-asserted-by":"crossref","unstructured":"Singh, A., Singh, K., Kaur, J., Kaur, R., Sharma, A., Kaur, J., Kaur, U., Chadha, R., & Bedi, P. M. S. (2023). Pathogenesis of Alzheimer's Disease and Diversity of 1,2,3-Triazole Scaffold in Drug Development: Design Strategies, Structural Insights, and Therapeutic Potential. ACS chemical neuroscience, 14(18), 3291\u20133317. 10.1021\/ acschemneuro.3c00393.","DOI":"10.1021\/acschemneuro.3c00393"},{"key":"10.1016\/j.bioorg.2024.107584_b0205","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jinorgbio.2016.04.022","article-title":"Multifunctional quinoline-triazole derivatives as potential modulators of amyloid-\u03b2 peptide aggregation","volume":"158","author":"Jones","year":"2016","journal-title":"J. Inorg. Biochem."},{"issue":"16","key":"10.1016\/j.bioorg.2024.107584_b0210","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1016\/j.bmcl.2016.07.017","article-title":"Synthesis and evaluation of novel 1,2,3-triazole-based acetylcholinesterase inhibitors with neuroprotective activity","volume":"26","author":"Li","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.bioorg.2024.107584_b0215","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3390\/ph16020179","article-title":"An Overview of 1,2,3-triazole-Containing Hybrids and Their Potential Anticholinesterase Activities","volume":"16","author":"Khan","year":"2023","journal-title":"Pharmaceuticals (basel, Switzerland)"},{"issue":"6","key":"10.1016\/j.bioorg.2024.107584_b0220","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/cplu.202000814","article-title":"Peptidotriazolamers Inhibit A\u03b2(1\u201342) Oligomerization and Cross a Blood-Brain-Barrier Model","volume":"86","author":"Tonali","year":"2021","journal-title":"ChemPlusChem"},{"key":"10.1016\/j.bioorg.2024.107584_b0225","doi-asserted-by":"crossref","unstructured":"de Carvalho da Silva, F., Cardoso, M.F.d.C., Ferreira, P.G., Ferreira, V.F. (2014). Biological Properties of 1H-1,2,3- and 2H-1,2,3-Triazoles. Springer International Publishing\uff0c117\u2013165. 10.1007\/7081_2014_124.","DOI":"10.1007\/7081_2014_124"},{"key":"10.1016\/j.bioorg.2024.107584_b0230","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bioorg.2017.01.010","article-title":"Medicinal attributes of 1,2,3-triazoles: Current developments","volume":"71","author":"Dheer","year":"2017","journal-title":"Bioorg. Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2024.107584_b0235","doi-asserted-by":"crossref","first-page":"6498","DOI":"10.1016\/j.bmcl.2012.08.036","article-title":"Design, synthesis and pharmacological evaluation of novel tacrine-caffeic acid hybrids as multi-targeted compounds against Alzheimer's disease","volume":"22","author":"Chao","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2024.107584_b0240","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejmech.2016.03.018","article-title":"Novel hederagenin-triazolyl derivatives as potential anti-cancer agents","volume":"115","author":"Rodr\u00edguez-Hern\u00e1ndez","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2024.107584_b0245","doi-asserted-by":"crossref","unstructured":"Sang, Z., Pan, W., Wang, K., Ma, Q., Yu, L., Yang, Y., Bai, P., Leng, C., Xu, Q., Li, X., Tan, Z., & Liu, W. (2017). Design, synthesis and evaluation of novel ferulic acid-O-alkylamine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease. European journal of medicinal chemistry, 130, 379\u2013392. 10.1016\/ j.ejmech.2017.02.039.","DOI":"10.1016\/j.ejmech.2017.02.039"},{"key":"10.1016\/j.bioorg.2024.107584_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/2380531","article-title":"New Caffeic Acid Phenylethyl Ester Analogs Bearing Substituted Triazole: Synthesis and Structure-Activity Relationship Study towards 5-Lipoxygenase Inhibition","volume":"2017","author":"Roy","year":"2017","journal-title":"J. Chem."},{"key":"10.1016\/j.bioorg.2024.107584_b0255","first-page":"953","article-title":"Synthesis and phytotoxic activity of 1,2,3-triazole derivatives","volume":"24","author":"Borgati","year":"2013","journal-title":"J. Braz. Chem. Soc."},{"key":"10.1016\/j.bioorg.2024.107584_b0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154245","article-title":"Autophagy activation by Terminalia chebula Retz. reduce A\u03b2 generation by shifting APP processing toward non-amyloidogenic pathway in APPswe transgenic SH-SY5Y cells","volume":"103","author":"Zhao","year":"2022","journal-title":"Phytomedicine : International Journal of Phytotherapy and Phytopharmacology"},{"key":"10.1016\/j.bioorg.2024.107584_b0265","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.lfs.2017.10.041","article-title":"Total flavonoid extract from Dracoephalum moldavica L. attenuates \u03b2-amyloid-induced toxicity through anti-amyloidogenesic and neurotrophic pathways","volume":"193","author":"Liu","year":"2018","journal-title":"Life Sci."},{"issue":"6","key":"10.1016\/j.bioorg.2024.107584_b0270","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1021\/acschemneuro.1c00535","article-title":"Donepezil-Inspired Multitargeting Indanone Derivatives as Effective Anti-Alzheimer's Agents","volume":"13","author":"Singh","year":"2022","journal-title":"ACS Chem. Nerosci."},{"issue":"10","key":"10.1016\/j.bioorg.2024.107584_b0275","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1007\/s11064-018-2622-8","article-title":"Effects of NMDAR Antagonist on the Regulation of P-MARCKS Protein to A\u03b21-42 Oligomers Induced Neurotoxicity","volume":"43","author":"Liu","year":"2018","journal-title":"Neurochem. Res."},{"issue":"13","key":"10.1016\/j.bioorg.2024.107584_b0280","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.3390\/cells12131726","article-title":"The Highs and Lows of Memantine-An Autophagy and Mitophagy Inducing Agent That Protects Mitochondria","volume":"12","author":"de Wet","year":"2023","journal-title":"Cells"},{"issue":"16","key":"10.1016\/j.bioorg.2024.107584_b0285","doi-asserted-by":"crossref","first-page":"5182","DOI":"10.3390\/molecules27165182","article-title":"Epidermal Growth Factor Receptor Kinase Inhibitor Ameliorates \u03b2-Amyloid Oligomer-Induced Alzheimer Disease in Swiss Albino Mice","volume":"27","author":"Dhamodharan","year":"2022","journal-title":"Molecules (basel, Switzerland)"},{"issue":"3","key":"10.1016\/j.bioorg.2024.107584_b0290","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jalz.2013.04.506","article-title":"CSF A\u03b21-42 combined with neuroimaging biomarkers in the early detection, diagnosis and prediction of Alzheimer's disease","volume":"10","author":"Lista","year":"2014","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.bioorg.2024.107584_b0295","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41583-019-0240-3","article-title":"Amyloid-\u03b2-independent regulators of tau pathology in Alzheimer disease","volume":"21","author":"van der Kant","year":"2020","journal-title":"Nat. Rev. Neurosci."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824004899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206824004899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T09:06:24Z","timestamp":1721207184000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206824004899"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":59,"alternative-id":["S0045206824004899"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107584","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of cinnamamide\/ester triazole hybrids as potential treatment for Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2024.107584","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107584"}}